Preclinical
Preclinical research is laboratory-stage science: studies done in cells, tissues, or animals before any testing in people.
Where the word comes from
Preclinical joins the Latin prefix prae-, “before,” to “clinical,” which traces to the Greek klinē, “bed.” Clinical literally means “at the bedside” — medicine done with a patient present. So preclinical means “before the bedside”: the research stage that comes before any human is involved. The formal split between laboratory studies and staged human trials took its modern shape in drug regulation during the mid-1900s.
What it means here
Most of the published literature on research peptides is preclinical. A finding in a mouse or a dish of cells shows a mechanism worth studying — it is not evidence about people, and many results that look strong in animals never repeat in human trials. That gap is why our pages label preclinical findings as preclinical instead of blending them into one story. Some compounds in this catalog, such as SLU-PP-332, have only preclinical evidence behind them, and their pages say so plainly. Reading the label tells a researcher what kind of evidence a claim sits on.
Words you’ll see together
- in vitro — Latin for “in glass”; studies done in cells or tissue outside a living body
- in vivo — Latin for “in the living”; studies done in whole animals
- animal model — an animal used to stand in for a condition being studied
- mechanism — the how of an effect, which preclinical work is best at showing
- translational — describes whether a lab finding carries over to humans
Related terms
- Clinical trial phases — the human-testing stages that come after preclinical work
- PubMed & DOI — the links that let a reader check whether a cited study was preclinical
- Research Use Only — the labeling category for compounds studied at this stage
Where it appears in our catalog
- SLU-PP-332 — a compound whose published evidence is entirely preclinical (mouse models)
- Semax — a peptide with a large preclinical mechanism literature
- Comparing compounds — how evidence stage figures into comparisons
References
- Billon C et al. (2024). A Synthetic ERR Agonist Alleviates Metabolic Syndrome. Journal of Pharmacology and Experimental Therapeutics. PMID 37739806
- Asadullah A et al. (2025). ACTH(4-10)-PGP (Semax) shifts anti-inflammatory cytokine expression in acute spinal-cord-injury preclinical models. F1000Research. PMID 41179234
